These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 23457753)

  • 1. I'm sorry, but I must object.
    Dixon GD
    Mo Med; 2013; 110(1):54-5. PubMed ID: 23457753
    [No Abstract]   [Full Text] [Related]  

  • 2. Commentary on payment and reimbursement issues affecting the marketing of drugs, medical devices, and biologics, with emphasis on the anti-kickback statute and Stark II.
    Reiss JB
    Food Drug Law J; 1997; 52(1):99-108. PubMed ID: 10346713
    [No Abstract]   [Full Text] [Related]  

  • 3. Nothing to hide, something to gain? how the US Sunshine Act may effect Canadian doctors.
    Rivers J
    J Cutan Med Surg; 2012; 16(3):145-8. PubMed ID: 22930849
    [No Abstract]   [Full Text] [Related]  

  • 4. Forecasting unanticipated consequences of "The Sunshine Act": mostly cloudy.
    Ratain MJ
    J Clin Oncol; 2014 Aug; 32(22):2293-5. PubMed ID: 24934789
    [No Abstract]   [Full Text] [Related]  

  • 5. Sunshine Act update.
    W V Med J; 2013; 109(5):40. PubMed ID: 24294711
    [No Abstract]   [Full Text] [Related]  

  • 6. How the Physician Payment Sunshine Act could affect practice revenue.
    J La State Med Soc; 2013; 165(6):305-7, 309-10. PubMed ID: 25073255
    [No Abstract]   [Full Text] [Related]  

  • 7. The Sunshine Act: how to avoid getting burned.
    Hurd P
    Fam Pract Manag; 2013; 20(5):8-10. PubMed ID: 24134101
    [No Abstract]   [Full Text] [Related]  

  • 8. Shedding light on what the Sunshine Act will mean for physicians.
    Katayama AC
    WMJ; 2012 Feb; 111(1):39-40. PubMed ID: 22533215
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmaceuticals and medical devices: business practices. End-of-year issue brief.
    Jones TM
    Issue Brief Health Policy Track Serv; 2010 Jan; ():1-58. PubMed ID: 20213918
    [No Abstract]   [Full Text] [Related]  

  • 10. Oversight of marketing relationships between physicians and the drug and device industry: a comparative study.
    Jost TS
    Am J Law Med; 2010; 36(2-3):326-42. PubMed ID: 20726399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CME shelter. Sunshine Act waiver for med ed payments may prompt marketing shift for product makers.
    Lee J
    Mod Healthc; 2014 Jun; 44(26):16-9. PubMed ID: 25134407
    [No Abstract]   [Full Text] [Related]  

  • 12. Transparency lacking. Despite Sunshine Act rules, policies still an issue.
    Lee J
    Mod Healthc; 2013 Mar; 43(10):10-1. PubMed ID: 23593894
    [No Abstract]   [Full Text] [Related]  

  • 13. Key opinion leaders and the corruption of medical knowledge: what the Sunshine Act will and won't cast light on.
    Sismondo S
    J Law Med Ethics; 2013; 41(3):635-43. PubMed ID: 24088154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sunlight as disinfectant--new rules on disclosure of industry payments to physicians.
    Rosenthal MB; Mello MM
    N Engl J Med; 2013 May; 368(22):2052-4. PubMed ID: 23718162
    [No Abstract]   [Full Text] [Related]  

  • 15. Conflict of interest in CME.
    Nelson R
    Iowa Med; 1994 Dec; 84(12):541. PubMed ID: 7843923
    [No Abstract]   [Full Text] [Related]  

  • 16. ACA "Sunshine Act & controlled substance database.
    Tenn Med; 2013 Apr; 106(4):11. PubMed ID: 23617033
    [No Abstract]   [Full Text] [Related]  

  • 17. The Sunshine Act--effects on physicians.
    Agrawal S; Brennan N; Budetti P
    N Engl J Med; 2013 May; 368(22):2054-7. PubMed ID: 23718163
    [No Abstract]   [Full Text] [Related]  

  • 18. Sunshine Act: 7 things you need to know.
    Treumann JE
    Med Econ; 2013 Mar; 90(6):64, 66-9. PubMed ID: 24066449
    [No Abstract]   [Full Text] [Related]  

  • 19. [Transparency alone is not sufficient for the management of conflicts of interest - pro].
    Lieb K
    Psychiatr Prax; 2015 Jan; 42(1):12-3. PubMed ID: 25585000
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmaceuticals and medical devices: business practices. End-of-year issue brief.
    Jones TM
    Issue Brief Health Policy Track Serv; 2008 Jan; ():1-32. PubMed ID: 18345554
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.